Science 37 Reports Second Quarter 2023 Financial Results
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
RESEARCH TRIANGLE PARK, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:…
Consolidated Revenues of $22.1B, Compared to $24.8B Last Year Consolidated Operating Profit of $2.8B; Adj….
Bagsværd, Denmark, 8 August 2023 – Novo Nordisk today announced the headline results from the…
CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) — Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical…
SEOUL, S.KOREA, Aug 8, 2023 – (JCN Newswire) – CanariaBio, a KOSDAQ-listed and a leading…
TOKYO, Aug 8, 2023 – (JCN Newswire) – Aichi Cancer Center and NEC Corporation’s research…
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as joint lead arranger on the funding of…
WiGL’s second phase of a multiyear contract with the U.S. Department of Defense will utilize…
Leading Voice AI, Cloud Contact Center, and SMS solution provider to speak and exhibit at…
Presentation to Provide In-depth Overview of How Virtual Agents Can Ensure Secure and Safe Use…
Mithra and Gedeon Richter Sign Supply Agreement for Production of API for Estelle® and Donesta®…
Vectra AI Platform arms security operations centers (SOC) with the integrated signal to deliver extended…
Odessa, Texas–(Newsfile Corp. – August 8, 2023) – Reyna Law Firm has brought forward new…
TOKYO, Aug 8, 2023 – (JCN Newswire) – Fujitsu today announced that it will start…
Tallinn, Estonia–(Newsfile Corp. – August 7, 2023) – Simple Traffic, a leading-edge targeted traffic generation…
TOKYO, Aug 8, 2023 – (JCN Newswire) – Hitachi, Ltd. (TSE: 6501) has received an…
NEW YORK–(BUSINESS WIRE)–Sixth Street Specialty Lending, Inc. (NYSE:TSLX) (“TSLX” or the “Company”) announced today that…
HONG KONG, Aug 8, 2023 – (ACN Newswire) – In February 2023, ChatGPT, OpenAI’s text-generating…
RIYADH, Aug 8, 2023 – (ACN Newswire) – The Saudi Film Commission is expected to…
LOS ANGELES, Aug. 07, 2023 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical…